Terms ending in 2030
Bayer Pharma Aktiengesellschaft
Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D748,244 | Electronic Autoinjector In force · High confidence | Bayer Pharma Aktiengesellschaft and Olufsen Medicom A/S, Corporation | In force | High confidence | |
| US D748,245 | Electronic Autoinjector In force · High confidence | Bayer Pharma Aktiengesellschaft and Bang & Olufsen Medicom A/S Corporation | In force | High confidence | |
| US 8,586,082 | Solid Orally Administerable Pharmaceutical Dosage Forms with Rapid Active Principle Release In force · High confidence | Bayer Intellectual Property GmbH | In force | High confidence | |
| US 9,084,829 | Anti-Mesothelin Immunoconjugates and Uses Therefor In force · High confidence | Bayer Intellectual Property GmbH | In force | High confidence | |
| US 10,155,004 | 17-Hydroxy-17-Pentafluoroethyl-ESTRA-4,9(10)-DIEN-11-ARYL Derivatives, Method of Production Thereof and Use Thereof for the Treatment of Diseases In force · Medium confidence | Bayer Intellectual Property GmbH | In force | Medium confidence | |
| US 11,617,751 | Pharmaceutical Composition Containing a Tetrahydrofolic Acid In force · Medium confidence | Bayer Intellectual Property GmbH | In force | Medium confidence | |
| US 9,233,176 | Systems and Method of Delivering Fluids to a Patient of Varying Concentration In force · High confidence | Bayer Intellectual Property GmbH | In force | High confidence | |
| US 9,018,414 | Substituted 3-Phenylpropionic Acids and the Use Thereof In force · Medium confidence | Bayer Intellectual Property GmbH | In force | Medium confidence | |
| US 8,784,775 | Compounds for Use in Imaging, Diagnosing And/Or Treatment of Diseases of the Central Nervous System or of Tumors In force · High confidence | Life Molecular Imaging Limited | In force | High confidence | |
| US 8,617,597 | Pharmaceutical Composition Containing a Tetrahydrofolic Acid In force · High confidence | Bayer Intellectual Property GmbH | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.